MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B5496 AMG 548Summary: P38α inhibitor,potent and selective
-
B5549 PF-3644022Target: MK2Summary: Potent and Selective MK2 inhibitor
-
B5593 PluripotinSummary: dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP
-
B5640 HI TOPK 032Summary: T-LAK-cell-originated protein kinase (TOPK) inhibitor
-
B6674 AnisomycinTarget: p38|JNK|SAPKSummary: JNK agonist, potent and specific
-
B6921 SKF 86002 dihydrochlorideSummary: p38 MAP kinase inhibitor
-
B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: inhibitor of p38α-mediated MK2a phosphorylation
-
B4727 B-Raf IN 1Summary: B-Raf inhibitor
-
B6673 KT 5823Summary: protein kinase G inhibitor
-
B6882 U0124Summary: Inactive analog of U0126(MEK-1/2 inhibitor), used as a negative control